When the M-CSF receptor (CD115) signaling activity was blocked using 100 nM PLX-3397, a significant reduction was shown in tumor CM-stimulated cells (53.82% of reversion in 3LL CM and 40.89% in MN/MCA CM) (Figure 3B). The gene discussed is CSF1R; the disease is neoplasm.